0001562180-15-001101.txt : 20151217 0001562180-15-001101.hdr.sgml : 20151217 20151217160158 ACCESSION NUMBER: 0001562180-15-001101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151215 FILED AS OF DATE: 20151217 DATE AS OF CHANGE: 20151217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tokai Pharmaceuticals Inc CENTRAL INDEX KEY: 0001404281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 255 STATE STREET STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-225-4348 MAIL ADDRESS: STREET 1: 255 STATE STREET STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kalowski Lee CENTRAL INDEX KEY: 0001618273 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36620 FILM NUMBER: 151293643 MAIL ADDRESS: STREET 1: C/O TOKAI PHARMACEUTICALS, INC. STREET 2: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2015-12-15 false 0001404281 Tokai Pharmaceuticals Inc TKAI 0001618273 Kalowski Lee C/O TOKAI PHARMACEUTICALS, INC. 255 STATE STREET 6TH FLOOR BOSTON MA 02109 false true false false Chief Financial Officer Stock Option (right to buy) 9.65 2015-12-15 4 A false 62000.00 0.00 A 2025-12-14 Common Stock 62000.00 62000.00 D This option vests with respect to 12.5% of the shares underlying the option vesting on June 30, 2016 and an additional 2.0833% on the last day of each month thereafter through December 31, 2019. /s/ Cindy Driscoll, Attorney-in-Fact 2015-12-17